o None
Entity Type
0000315545
PROVECTUS PHARMACEUTICALS INC
ZAMAGE DIGITAL IMAGING INC
SPM GROUP INC
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 PROVECTUS BIOPHARMACEUTICALS, INC.
Jurisdiction of Incorporation/Organization
DELAWARE
 
Year of Incorporation/Organization
  x Over Five Years Ago
  o Within Last Five Years (Specify Year)  
  o Yet to Be Formed  



2. Principal Place of Business and Contact Information
Name of Issuer  
 PROVECTUS BIOPHARMACEUTICALS, INC.  
Street Address 1 Street Address 2
 10025 INVESTMENT DRIVE  SUITE 250
City State/Province/Country ZIP/Postal Code Phone No. of Issuer
 KNOXVILLE  TENNESSEE  37932  866-594-5999 



3. Related Persons
Last Name First Name Middle Name
Bailey Webster
Street Address 1 Street Address 2
10025 Investment Drive Suite 250
City State/Province/Country ZIP/Postal Code
Knoxville TENNESSEE 37932
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
   

Last Name First Name Middle Name
Horowitz Bruce
Street Address 1 Street Address 2
10025 Investment Drive Suite 250
City State/Province/Country ZIP/Postal Code
Knoxville TENNESSEE 37932
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
   

Last Name First Name Middle Name
Lacey, III John
Street Address 1 Street Address 2
10025 Investment Drive Suite 250
City State/Province/Country ZIP/Postal Code
Knoxville TENNESSEE 37932
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
   

Last Name First Name Middle Name
Pershing Ed
Street Address 1 Street Address 2
10025 Investment Drive Suite 250
City State/Province/Country ZIP/Postal Code
Knoxville TENNESSEE 37932
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
   

 
Last Name First Name Middle Name
Rodrigues Dominic
Street Address 1 Street Address 2
10025 Investment Drive Suite 250
City State/Province/Country ZIP/Postal Code
Knoxville TENNESSEE 37932
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
   

Last Name First Name Middle Name
Raines Heather
Street Address 1 Street Address 2
10025 Investment Drive Suite 250
City State/Province/Country ZIP/Postal Code
Knoxville TENNESSEE 37932
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
   

Last Name First Name Middle Name
Wachter Eric
Street Address 1 Street Address 2
10025 Investment Drive Suite 250
City State/Province/Country ZIP/Postal Code
Knoxville TENNESSEE 37932
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
   

 


4. Industry Group
o Agriculture   Health Care o Retailing
  Banking & Financial Services   o Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance   Technology
  o Insurance   o Hospitals & Physicians   o Computers
  o Investing   x Pharmaceuticals   o Telecommunications
  o Investment Banking   o Other Health Care   o Other Technology
  o Pooled Investment Fund

        Travel
  o Other Banking & Financial Services o Manufacturing   o Airlines & Airports
  Real Estate   o Lodging & Conventions
  o Commercial   o Tourism & Travel Services
  o Construction   o Other Travel
  o REITS & Finance o Other
  o Residential  
  o Other Real Estate  
o Business Services  
  Energy  
  o Coal Mining  
  o Electric Utilities  
  o Energy Conservation  
  o Environmental Services  
  o Oil & Gas  
  o Other Energy  


5. Issuer Size
Revenue Range Aggregate Net Asset Value Range
x No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
o Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) x Rule 506(b)
o Rule 504 (b)(1)(ii) o Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale  2021-08-16 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests o Equity
o Tenant-in-Common Securities x Debt
o Mineral Property Securities o Option, Warrant or Other Right to Acquire Another Security
x Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security o Other (describe)
   


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? o Yes x No
 
Clarification of Response (if Necessary)  
  

11. Minimum Investment
Minimum investment accepted from any outside investor $ 0 USD

12. Sales Compensation
Recipient Recipient CRD Number o None
   
(Associated) Broker or Dealer o None (Associated) Broker or Dealer CRD Number o None
   
Street Address 1 Street Address 2
   
City State/Province/Country ZIP/Postal Code
     
State(s) of Solicitation o All States
 
 



13. Offering and Sales Amounts
Total Offering Amount $ 5000000 USD o Indefinite
Total Amount Sold $ 200000 USD  
Total Remaining to be Sold $ 4800000 USD o Indefinite
 
Clarification of Response (if Necessary)
  


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
 
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 1


15. Sales Commissions & Finders’ Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions $ 0 USD o Estimate
Finders' Fees $ 0 USD o Estimate
 
Clarification of Response (if Necessary)
  


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
  $ 0 USD o
Provectus Biopharmaceuti... (QB) (USOTC:PVCT)
Historical Stock Chart
From Nov 2021 to Dec 2021 Click Here for more Provectus Biopharmaceuti... (QB) Charts.
Provectus Biopharmaceuti... (QB) (USOTC:PVCT)
Historical Stock Chart
From Dec 2020 to Dec 2021 Click Here for more Provectus Biopharmaceuti... (QB) Charts.